<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>Use ACE I in Renal Artery Stenosis • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="Use ACE I in Renal Artery Stenosis • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/use ACE I in renal artery stenosis/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/use ACE I in renal artery stenosis/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1 id="use-ace-i-in-renal-artery-stenosis" tabindex="-1">use ACE I in renal artery stenosis</h1>
<ul>
<li>related: <a href="/wiki/notes/Nephrology/">Nephrology</a></li>
<li>tags: #nephrology</li>
</ul>
<hr>
<p>This elderly patient who has uncontrolled hypertension despite multidrug therapy and is found to have high-grade <strong>bilateral renal artery stenosis</strong> (&gt;60% stenosis) should be treated with an ACE inhibitor.</p>
<p><mark>Bilateral renal ischemia</mark> (caused by limited blood supply to the poststenotic kidney) induces the activation of the renin-angiotensin-aldosterone system <mark>(RAAS)</mark>, which leads to sodium retention and volume expansion.  As the RAAS is involved, a combination of a diuretic with an ACE inhibitor or angiotensin receptor blocker (ARB) is the preferred initial treatment.  <strong><mark>ACE inhibitors</mark></strong> have been shown to decrease mortality, rate of myocardial infarction, progression to end-stage renal disease, and stroke and are equally as effective as angioplasty in most patients.</p>
<p>Patients with <strong>bilateral</strong> renal artery stenosis are at increased risk of development of acute kidney injury; however, ACE inhibitors and ARBs are <strong>==no longer</strong> thought to be <strong>contraindicated==</strong> in this population as most patients only experience a small decline in glomerular filtration rate.  More marked declines are usually reversible with dose reduction or elimination of the diuretic; patients should be <mark>monitored closely</mark> while on these medications.  Other antihypertensive agents and statins, as well as antiplatelet therapy should be added when appropriate along with lifestyle changes.</p>
<p>Patients who fail optimal medical therapy (eg, refractory hypertension, inability to tolerate medications, progressive renal insufficiency) or those with recurrent flash pulmonary edema or heart failure should undergo revascularization with stenting <strong>(Choice D)</strong>.</p>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Nephrology/" class="peer">Nephrology</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="nephrology" tabindex="-1">Nephrology</h1>
<hr>
<ul>
<li>Keywords:: <a href="/wiki/notes/Step%203/">Step 3</a>, <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<hr>
<h2 id="to-learns" tabindex="-1">To learns</h2>
<ul>
<li>ANCA vasculitis</li>
<li>[ ] stones: citrate and calcium physiology</li>
</ul>
<h2 id="mksap" tabindex="-1">MKSAP</h2>
<p>Chapter 01Clinical Evaluation of Kidney Function
Chapter 02Fluids and Electrolytes
Chapter 03Acid-Base Disorders
Chapter 04Hypertension
Chapter 05Chronic Tubulointerstitial Nephritis
Chapter 06Glomerular Diseases</p>
<ul>
<li><a href="/wiki/notes/Kidney%20Manifestations%20of%20Deposition%20Diseases/">Kidney Manifestations of Deposition Diseases</a>
Chapter 08Genetic Disorders and Kidney Disease
Chapter 09Acut</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
